A Vancouver-based research team led by Canada's most cited neuroscientist, Dr. Patrick McGeer, has successfully carried out studies suggesting that, if started early enough, a daily regimen of the non-prescription NSAID (nonsteroidal anti-inflammatory drug) ibuprofen can prevent the onset of Alzheimer's disease. This means that by taking an over-the-counter medication, people can ward off a disease that, according to Alzheimer's Disease International's World Alzheimer Report 2016, affects an estimated 47 million people worldwide, costs health care systems worldwide more than US$818 billion per year and is the fifth leading cause of death in those aged 65 or older.It actually goes on to talk more about testing saliva to see if people are likely to develop Alzheimer's, rather than the protective effects of ibuprofen. Seems very PR department written, if you ask me...
Tuesday, March 27, 2018
This article seems to involve a little too much self-promotion, but if true, it's good news: